Inhibiting TNF has shown remarkable therapeutic benefits in patients with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, juvenile arthritis and many other less prevalent diseases. This evidence concerns the gene TNF and Crohn disease.